SCHEMBL179276

SCHEMBL179276

CC(C)(C)n1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL4871761 0.97 KCNN4 (0.35)
SCHEMBL15999961 0.83 KCNN4 (0.36)
SCHEMBL30203104 0.82
SCHEMBL7828005 0.79 KCNN4 (0.34)
SCHEMBL3372959 0.79
SCHEMBL23689890 0.79
SCHEMBL12349925 0.79 KCNN4 (0.34)
SCHEMBL3971146 0.79
SCHEMBL15198095 0.75 KCNN4 (0.33)
SCHEMBL12115800 0.75 KCNN4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1487 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158025-A1 GALACTOKINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH 2023-05-25 US claimed
CN-109456200-B Preparation method of m-xylylenediamine 万华化学集团股份有限公司 2021-07-23 CN claimed
EP-2614065-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS Nerviano Medical Sciences S.r.l. (IT) 2013-07-17 EP claimed
WO-2012080990-A1 SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-06-21 WO claimed
US-20100160324-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES ASTEX THERAPEUTICS LIMITED (GB) 2010-06-24 US claimed
EP-1836188-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES Astex Therapeutics Limited (GB) 2007-09-26 EP claimed
WO-2006070198-A1 PYRAZOLE DERIVATIVES AS THAT MODULATE THE ACTIVITY OF CDK, GSK AND AURORA KINASES ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO claimed
WO-2002012161-A1 PROCESS FOR THE CARBONYLATION OF OXIRANES DAVY PROCESS TECHNOLOGY LIMITED (GB) 2002-02-14 WO claimed
EP-1179524-A1 Process for the carbonylation of oxiranes Kvaerner Process Technology Limited (GB) 2002-02-13 EP claimed
EP-0286279-A1 Synthesis of substituted pyrazoles ELI LILLY AND COMPANY (US) 1988-10-12 EP claimed
US-12624018-B1 Inhibitors of RIPK2 and medical uses thereof ODYSSEY THERAPEUTICS, INC. (US) 2026-05-12 US disclosed
US-20260116859-A1 Charged Ion Channel Blockers and Methods for Use NOCION THERAPEUTICS INC (US) 2026-04-30 US disclosed
US-20250263408-A1 SPLEEN TYROSINE KINASE INHIBITORS UNIQUEST PTY LTD (AU) 2025-08-21 US disclosed
CN-119965352-A Application of trifluoromethyl pyrazolyl dimethyl phosphonate isomer compound in electrolyte, electrolyte additive and lithium ion battery electrolyte 华鼎国联动力电池有限公司 2025-05-09 CN disclosed
US-20250049776-A1 AUTOPHAGY INDUCING COMPOUNDS AND USES THEREOF, IN PARTICULAR FOR A SYSTEMIC TREATMENT OF DISEASES AND CONDITIONS INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) (FR) 2025-02-13 US disclosed
EP-0412849-B1 Azole pesticides AGREVO UK LTD (GB) 1995-12-20 EP disclosed
EP-0412849-A2 Azole pesticides AgrEvo UK Limited (GB) 1991-02-13 EP disclosed
US-4820845-A Alkylation of 3(5)-cyano-1H-pyrazole-4-carboxylic acid esters ELI LILLY AND COMPANY (US) 1989-04-11 US disclosed
EP-0286279-A1 Synthesis of substituted pyrazoles ELI LILLY AND COMPANY (US) 1988-10-12 EP disclosed
EP-0139182-A2 Herbicidal agents containing a photosynthesis inhibitor herbicide together with 1,4-disubstituted pyrazole derivatives BAYER AG (DE) 1985-05-02 EP disclosed